PBGENE-DMD Gene Editing Therapy: Benefits, Eligibility, and FAQs
PBGENE-DMD Gene Editing Therapy is an investigational, first-in-class treatment developed by Precision BioSciences for Duchenne muscular dystrophy (DMD).Unlike traditional therapies, PBGENE-DMD uses a gene...
Why CK, AST, and ALT Data Matter More Than Videos in Duchenne Gene Therapy
In the evolving landscape of gene therapy for Duchenne muscular dystrophy (DMD), one issue is becoming increasingly clear: CK levels after Duchenne gene therapy...
Duchenne Muscular Dystrophy Treatment Access: A Global Failure of Equity, Policy, and Accountability
Duchenne muscular dystrophy (DMD) is no longer a condition defined solely by its biology. Today, it is equally defined by who can access treatment—and...
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
The landscape of potential new gene therapies for Duchenne muscular dystrophy (DMD) is rapidly evolving, offering renewed hope for patients and families affected by...
The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control
The duchenne muscular dystrophy treatment cost has become one of the most controversial and morally troubling issues in modern medicine. From duchenne therapy cost...